Clinical Trials
1
Active:0
Completed:1
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and Influenza Treatment System With Machine Learning
Completed
- Conditions
- COVID-19InfluenzaPost-COVID-19 Syndrome
- First Posted Date
- 2023-09-25
- Last Posted Date
- 2023-12-29
- Lead Sponsor
- Lizora LLC
- Target Recruit Count
- 27
- Registration Number
- NCT06052527
- Locations
- π¨π³
Sheng'Ai Traditional Medicine Hospital, Kunming, Yunnan, China
News
No news found